Debiovision’s Sanvar Will Be Tough Sell To Advisory Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA has declared any positive results from a study of vapreotide to be statistically insignificant, immeasurably biased and possibly due to the endoscopic therapy rather than the drug.